KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Invested Capital: 2019-2025

Historic Return on Invested Capital for Moderna (MRNA) over the last 4 years, with Sep 2025 value amounting to -0.36%.

  • Moderna's Return on Invested Capital was N/A to -0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.36%, marking a year-over-year change of. This contributed to the annual value of -0.31% for FY2024, which is N/A change from last year.
  • Per Moderna's latest filing, its Return on Invested Capital stood at -0.36% for Q3 2025, which was down 10.25% from -0.33% recorded in Q2 2025.
  • Moderna's Return on Invested Capital's 5-year high stood at 0.96% during Q4 2021, with a 5-year trough of -0.36% in Q3 2025.
  • Its 3-year average for Return on Invested Capital is -0.23%, with a median of -0.33% in 2025.
  • As far as peak fluctuations go, Moderna's Return on Invested Capital soared by 72bps in 2022, and later slumped by 66bps in 2023.
  • Over the past 5 years, Moderna's Return on Invested Capital (Quarterly) stood at 0.96% in 2021, then tumbled by 54bps to 0.42% in 2022, then tumbled by 66bps to 0.23% in 2023, then reached -0.32% in 2024, then reached -0.36% in 2025.
  • Its Return on Invested Capital was -0.36% in Q3 2025, compared to -0.33% in Q2 2025 and -0.35% in Q1 2025.